Cargando…

Experimentally‐induced anti‐myeloperoxidase vasculitis does not require properdin, MASP‐2 or bone marrow‐derived C5

Anti‐neutrophil cytoplasmic antibody vasculitis is a systemic autoimmune disease with glomerulonephritis and pulmonary haemorrhage as major clinical manifestations. The name reflects the presence of autoantibodies to myeloperoxidase and proteinase‐3, which bind to both neutrophils and monocytes. Evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freeley, Simon J, Popat, Reena J, Parmar, Kiran, Kolev, Martin, Hunt, Beverley J, Stover, Cordula M, Schwaeble, Willhelm, Kemper, Claudia, Robson, Michael G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2016
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996338/ https://www.ncbi.nlm.nih.gov/pubmed/27235854 http://dx.doi.org/10.1002/path.4754

Ejemplares similares

Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis
por: Dimitrova, Petya, et al.
Publicado: (2012)

Experimentally Induced Anti-Myeloperoxidase Vasculitis Is Not Attenuated in Factor B or VISTA Deficient Mice
por: Flórez-Barrós, Fernanda, et al.
Publicado: (2021)

Properdin Levels in Human Sepsis
por: Stover, Cordula M., et al.
Publicado: (2015)

Complement Properdin Determines Disease Activity in MRL/lpr Mice
por: Alaridhee, Hasanain, et al.
Publicado: (2020)

Prognostic Value of Complement Properdin in Cancer
por: Mangogna, Alessandro, et al.
Publicado: (2021)

Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin
por: Dupont, Aline, et al.
Publicado: (2014)

Tumour cell conditioned medium reveals greater M2 skewing of macrophages in the absence of properdin
por: Al‐Rayahi, Izzat A.M., et al.
Publicado: (2017)

Protective Role for Properdin in Progression of Experimental Murine Atherosclerosis
por: Steiner, Tanja, et al.
Publicado: (2014)

Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model
por: Al-Rayahi, Izzat A. M., et al.
Publicado: (2021)

Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction
por: Clark, James, E, et al.
Publicado: (2018)

Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development
por: Popat, Reena J., et al.
Publicado: (2017)

Properdin: A Novel Target for Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury
por: Sisa, Claudia, et al.
Publicado: (2019)

Mannan binding lectin-associated serine protease-2 (MASP-2) critically contributes to post-ischemic brain injury independent of MASP-1
por: Orsini, Franca, et al.
Publicado: (2016)

Complement Properdin Regulates the Metabolo-Inflammatory Response to a High Fat Diet
por: Thomas, Rόisín C., et al.
Publicado: (2020)

Properdin and Factor H: Opposing Players on the Alternative Complement Pathway “See-Saw”
por: Kouser, Lubna, et al.
Publicado: (2013)

Myeloid expression of the anti-apoptotic protein Mcl1 is required in anti-myeloperoxidase vasculitis but myeloperoxidase inhibition is not protective
por: Florez-Barros, Fernanda, et al.
Publicado: (2023)

Properdin Deficiency Impairs Phagocytosis and Enhances Injury at Kidney Repair Phase Post Ischemia–Reperfusion
por: Wu, Yuanyuan, et al.
Publicado: (2021)

PROPERDIN FACTOR D : II. ACTIVATION TO D BY PROPERDIN
por: Fearon, Douglas T., et al.
Publicado: (1974)

THE PROPERDIN SYSTEM AND IMMUNITY : III. THE ZYMOSAN ASSAY OF PROPERDIN
por: Pillemer, Louis, et al.
Publicado: (1956)

THE PROPERDIN SYSTEM AND IMMUNITY : III. THE ZYMOSAN ASSAY OF PROPERDIN
por: Pillemer, Louis, et al.
Publicado: (1956)

Polymorphisms in the MASP1 Gene Are Associated with Serum Levels of MASP-1, MASP-3, and MAp44
por: Gytz Ammitzbøll, Christian, et al.
Publicado: (2013)

THE PROPERDIN SYSTEM AND IMMUNITY : VI. THE INACTIVATION OF NEWCASTLE DISEASE VIRUS BY THE PROPERDIN SYSTEM
por: Wedgwood, Ralph J., et al.
Publicado: (1956)

Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy
por: Michels, Marloes A. H. M., et al.
Publicado: (2019)

THE PROPERDIN SYSTEM AND IMMUNITY : V. THE BACTERICIDAL ACTIVITY OF THE PROPERDIN SYSTEM
por: Wardlaw, Alastair C., et al.
Publicado: (1956)

Toll-Like Receptor 2 or Toll-Like Receptor 4 Deficiency Does Not Modify Lupus in MRLlpr Mice
por: Freeley, Simon J., et al.
Publicado: (2013)

Native myeloperoxidase is required to make the experimental vasculitis model
por: Nonokawa, Mayu, et al.
Publicado: (2019)

MASP-1 Induced Clotting – The First Model of Prothrombin Activation by MASP-1
por: Jenny, Lorenz, et al.
Publicado: (2015)

Association of MASP-2 Levels and MASP2 Gene Polymorphisms with Rheumatoid Arthritis in Patients and Their Relatives
por: Goeldner, Isabela, et al.
Publicado: (2014)

QUANTITATIVE STUDIES ON THE PROPERDIN-COMPLEMENT SYSTEM : II. KINETICS OF THE REACTION BETWEEN PROPERDIN AND ZYMOSAN
por: Leon, Myron A.
Publicado: (1957)

THE PROPERDIN SYSTEM AND IMMUNITY : VII. ALTERATIONS IN PROPERDIN LEVELS AND RESISTANCE TO INFECTION IN MICE FOLLOWING THE ADMINISTRATION OF TISSUE POLYSACCHARIDES
por: Pillemer, Louis, et al.
Publicado: (1957)

Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus
por: Xu, Wang‐Dong, et al.
Publicado: (2020)

Phosphatidylinositol 3‐Kinase δ Deficiency Protects From Antimyeloperoxidase Vasculitis
por: Flórez‐Barrós, Fernanda, et al.
Publicado: (2022)

AN ALTERNATIVE MECHANISM FOR THE PROPERDIN SYSTEM
por: Nelson, Robert A.
Publicado: (1958)

Targeted deletions of complement lectin pathway genes improve outcome in traumatic brain injury, with MASP-2 playing a major role
por: Mercurio, D., et al.
Publicado: (2020)

Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement
Publicado: (1976)

Human Properdin Opsonizes Nanoparticles and Triggers a Potent Pro-inflammatory Response by Macrophages without Involving Complement Activation
por: Kouser, Lubna, et al.
Publicado: (2018)

MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression
por: Maestri, Carlos Afonso, et al.
Publicado: (2018)

THE ROLE OF PROPERDIN IN THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION
por: Götze, Otto, et al.
Publicado: (1974)

Pulmonary fibrosis—an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?
por: Bhanji, Amir, et al.
Publicado: (2010)

Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-Associated Vasculitis
por: Gou, Shen-Ju, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hbt2iiccq87v3qpb4oc9l1lla5